IRIDEX (NASDAQ:IRIX) Issues Earnings Results

IRIDEX (NASDAQ:IRIX) posted its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.12) earnings per share for the quarter, Zacks reports. IRIDEX had a negative return on equity of 163.45% and a negative net margin of 22.79%. The firm had revenue of $11.58 million for the quarter. During the same quarter in the prior year, the business posted ($0.11) earnings per share.

IRIDEX Price Performance

NASDAQ:IRIX opened at $1.80 on Thursday. IRIDEX has a one year low of $1.27 and a one year high of $3.65. The company has a market cap of $29.75 million, a PE ratio of -2.82 and a beta of 0.80. The firm has a 50-day moving average of $1.68 and a 200-day moving average of $2.03.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on IRIDEX in a research report on Saturday, November 9th. They set a “hold” rating on the stock.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.